BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 4404295)

  • 1. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
    Salvesen C; Vaksdal K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
    Richou H
    Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problems of use trials of long-acting tranquilizers in acute psychiatric syndromes].
    Ropert R; Lévy L; Ropert M
    Ann Med Psychol (Paris); 1973 Feb; 2(2):259-67. PubMed ID: 4147917
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 8. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L; Escande M; Fournié H; Perretti A
    Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncontrolled study with pipothiazine palmitate.
    Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
    Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D; Péron-Magnan P
    Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR; Lavallee B
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the activity of 2 neuroleptics].
    Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM
    Encephale; 1970; 59(2):97-161. PubMed ID: 5458713
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
    Dencker SJ; Frankenberg K; Malm U; Zell B
    Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
    [No Abstract]   [Full Text] [Related]  

  • 18. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 19. General evaluation of pipotiazine palmitate in hospitalized and open ward patients with functional psychosis.
    Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 241():57-67. PubMed ID: 4147512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of fluphenazine use since establishment of a psychiatric section].
    Roger BM
    Ann Med Psychol (Paris); 1972 Apr; 1(4):550-5. PubMed ID: 4342755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.